[Effect of cream base IXa (Decoderm Basiscream) on toxic-degenerative skin diseases].
D000152:Acne Vulgaris / Q000188:drug therapy; D000818:Animals; D003876:Dermatitis, Atopic / Q000188:drug therapy; D009783:Dermatitis, Occupational / Q000188:drug therapy*; D012628:Dermatitis, Seborrheic / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D007642:Keratosis / Q000188:drug therapy; D008010:Lichen Planus / Q000188:drug therapy; D008297:Male; D009823:Ointment Bases / Q000627:therapeutic use*; D010592:Pharmaceutic Aids / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy
D009823:Ointment Bases; D010592:Pharmaceutic Aids
Der Einfluss der Cremegrundlage IXa (Decoderm Basiscreme) auf toxisch-degenerative Hautschäden